Topical fibroblast growth factor‐2 for treatment of chronic tympanic membrane perforations

Topical fibroblast growth factor‐2 for treatment of chronic tympanic membrane perforations

Abstract Objective To determine the efficacy of fibroblast growth factor‐2 (FGF‐2) in treating chronic nonhealing tympanic membrane (TM) perforations. Method Double‐blinded, randomized placebo controlled phase 2 clinical trial for patients with chronic TM perforations of more than 3 months duration...

Full description

Bibliographic Details
Main Authors: Felipe Santos, Edina Shu, Daniel J. Lee, David H. Jung, Alicia M. Quesnel, Konstantina M. Stankovic, Dunia E. Abdul‐Aziz, Camden P. Bay, Amy Quinkert, D. Bradley Welling
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Laryngoscope Investigative Otolaryngology
Subjects:
basic FGF
bFGF
chronic tympanic membrane perforation
FGF2
fibroblast growth factor
growth factor
Online Access:https://doi.org/10.1002/lio2.395

Internet

https://doi.org/10.1002/lio2.395

Similar Items